Resistance and allergy to recombinant human insulin (Q46699953)

24 December 2017

title

Resistance and allergy to recombinant human insulin (English)

1 reference

24 December 2017

author

Leslie C. Grammer

7

1 reference

24 December 2017

author name string

Ganz MA

1

1 reference

24 December 2017

Unterman T

2

1 reference

24 December 2017

Roberts M

3

1 reference

24 December 2017

Uy R

4

1 reference

24 December 2017

Sahgal S

5

1 reference

24 December 2017

Samter M

6

1 reference

24 December 2017

language of work or name

English

0 references

publication date

1 July 1990

1 reference

24 December 2017

The Journal of Allergy and Clinical Immunology

published in

1 reference

24 December 2017

volume

86

1 reference

24 December 2017

issue

1

1 reference

24 December 2017

page(s)

45-51

1 reference

24 December 2017

Insulin antibodies in the pathogenesis of insulin allergy and resistance

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2805%2980122-8

7 January 2021

Hypoglycemia due to serum-complexed insulin in a patient with diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2805%2980122-8

7 January 2021

Prolonged fasting hypoglycemia due to insulin antibodies in patient with non-insulin-dependent diabetes mellitus: effect of insulin withdrawal on insulin-antibody-binding kinetics.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2805%2980122-8

7 January 2021

Spontaneous hypoglycemia associated with autoimmunity specific to human insulin.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2805%2980122-8

7 January 2021

Characterization of circulating insulin and proinsulin-binding antibodies in autoimmune hypoglycemia

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2805%2980122-8

7 January 2021

Insulin autoimmunity as a cause of hypoglycemia.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2805%2980122-8

7 January 2021

Hypoglycemia due to apparent autoantibodies to insulin. Characterization of insulin-binding protein

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2805%2980122-8

7 January 2021

The immunogenicity of new insulins

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2805%2980122-8

7 January 2021

The immunogenicity of insulin preparation. Antibody levels before and after transfer to highly purified porcine insulin

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2805%2980122-8

7 January 2021

Development of IgE antibodies to human (recombinant DNA), porcine, and bovine insulins in diabetic subjects.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2805%2980122-8

7 January 2021

Insulin allergy treated with human insulin (recombinant DNA).

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2805%2980122-8

7 January 2021

Desensitization with human (recombinant DNA) insulin

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2805%2980122-8

7 January 2021

Cutaneous allergy to human (recombinant DNA) insulin

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2805%2980122-8

7 January 2021

A Simple Method for the Determination of Serum Free Insulin Levels in Insulin-treated Patients

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2805%2980122-8

7 January 2021

Monoiodoinsulin: Demonstration of its biological activity and binding to fat cells and liver membranes

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2805%2980122-8

7 January 2021

Isolation of the insulin receptor of liver and fat-cell membranes (detergent-solubilized-( 125 I)insulin-polyethylene glycol precipitation-sephadex)

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2805%2980122-8

7 January 2021

Equilibrium binding assay and kinetic characterization of insulin antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2805%2980122-8

7 January 2021

Effect of anti-insulin antibodies on glycemic control in insulin treated diabetic patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2805%2980122-8

7 January 2021

Circulating insulin-binding antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2805%2980122-8

7 January 2021

Effect of insulin antibodies and their kinetic characteristics on plasma free insulin dynamics in patients with diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2805%2980122-8

7 January 2021

In search of the subcutaneous-insulin-resistance syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2805%2980122-8

7 January 2021

IgE antibody studies in a case of generalized allergic reaction to human insulin

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2805%2980122-8

7 January 2021

The incidence of skin reactivity to insulin in diabetic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2805%2980122-8

7 January 2021

10.1016/S0091-6749(05)80122-8

Identifiers

DOI

1 reference

24 December 2017

PubMed ID

2196303

1 reference

24 December 2017